NCT02184052已完成不适用
Meloxicam (MOBIC®) Ampoule Post Marketing Surveillance Study
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 121
- 主要终点
- Overall assessment of degree of pain on a 3-point scale
研究概览
简要总结
Study to determine the safety and efficacy of Mobic® ampoules in the initiation of treatment of painful exacerbations of osteoarthritis, rheumatoid arthritis and other similar painful inflammatory conditions.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Painful acute exacerbations of inflammatory rheumatism (rheumatoid arthritis and ankylosing spondylitis), painful acute exacerbations of osteoarthritis and other similar conditions requiring acute treatment with an anti-inflammatory drug
排除标准
- 未提供
研究组 & 干预措施
Meloxicam
干预措施: Meloxicam (Drug)
结局指标
主要结局
Overall assessment of degree of pain on a 3-point scale
时间窗: up to 3 days
次要结局
- Number of patients with adverse events(up to 3 days)
研究者
相似试验
尚未招募
2 期
Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal SurgeryPain, Post-operativeNCT05950152Beijing Tide Pharmaceutical Co., Ltd108
已完成
不适用
Observational Study of Meloxicam in Mexican Patients With Rheumatic DiseasesArthritis, RheumatoidNCT02184065Boehringer Ingelheim22,639
已完成
不适用
Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm SyndromeArthritis, RheumatoidNCT02180516Boehringer Ingelheim9,984
已完成
3 期
Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)Total Knee ReplacementTotal Hip ReplacementNCT05291598University of Miami223
已完成
2 期
Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third MolarPainNCT02183051Boehringer Ingelheim381